You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 271 No. 15, April 20, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sexually Transmitted Diseases and Other Risk Factors for Cervical Dysplasia Among Southwestern Hispanic and Non-Hispanic White Women

Thomas M. Becker, MD; Cosette M. Wheeler, PhD; Nancy S. McGough, CNP; Cheryl A. Parmenter; Scott W. Jordan, MD; Christine A. Stidley, PhD; R. Sue McPherson, PhD; Maxine H. Dorin, MD

JAMA. 1994;271(15):1181-1188.


Abstract

Objective.
—To assess risk factors for high-grade cervical dysplasia among southwestern Hispanic and non-Hispanic white women.

Design.
—Clinic-based case-control study.

Setting.
—University-affiliated gynecology clinics.

Subjects.
—Cases were Hispanic and non-Hispanic white women with biopsy-proven high-grade cervical dysplasia (n=201). Controls were Hispanic and non-Hispanic white women from the same clinics with normal cervical epithelium (n=337).

Methods.
—Study design included interviews focused on histories of sexually transmitted diseases, sexual behavior, reproductive histories, hygienic practices, contraceptive use, cigarette smoking, and diet. Laboratory studies included bacterial and protozoal cultures of the cervix; hybridization tests to identify human papillomavirus (HPV) genome with commercial (ViraPap and ViraType) and polymerase chain reaction—based assays; and serum antibody tests for herpes simplex virus, Chlamydia trachomatis, syphilis, hepatitis B, and hepatitis C.

Results.
—For both ethnic groups combined, after adjustment for ethnicity, age, and sexual behavior, the strongest risks for cervical dysplasia were associated with cervical HPV infection as identified by ViraPap (odds ratio [OR], 12.8; 95% confidence interval [Cl], 8.2 to 20.0) or with polymerase chain reaction (OR, 20.8; 95% Cl, 10.8 to 40.2). Other factors associated with dysplasia included cigarette smoking at the time of diagnosis (OR, 1.8; 95% Cl, 1.2 to 2.8); low income (OR, 2.2; 95% Cl, 1.2 to 4.0); low educational level (OR, 6.2; 95% Cl, 3.4 to 11.1); history of any sexually transmitted disease (OR, 1.9; 95% Cl, 1.3 to 2.7); and seroprevalence of antibodies to hepatitis B (OR, 1.8; 95% Cl, 0.9 to 3.5). For Hispanic women, HPV 16/18 identified by ViraType was strongly associated with cervical dysplasia (OR, 171.0; 95% Cl, 22.8 to 1280.5). Antibodies to herpes simplex virus type 2 were not associated with dysplasia in Hispanic women but were significantly associated with dysplasia among non-Hispanic whites. Risks associated with cigarette smoking also varied by ethnic group.

Conclusions.
—The strongest risk factor associated with high-grade cervical dysplasia among clinic attendees was HPV infection. Although most of the risk factors we examined showed similar associations for dysplasia for both ethnic groups, our data suggest that several different risk factors may be relevant to the development of cervical dysplasia in Hispanics compared with non-Hispanic whites who attend the same clinics.

(JAMA. 1994;271:1181-1188)



Author Affiliations

From the University of New Mexico School of Medicine, Albuquerque (Drs Becker, Wheeler, Jordan, Stidley, and Dorin and Mss McGough and Parmenter), and University of Texas at Houston School of Public Health; (Dr McPherson).


Footnotes

Reprint requests to New Mexico Tumor Registry, Cancer Center, University of New Mexico School of Medicine, Albuquerque, NM 87 131-5306 (Dr Becker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluation of Different Techniques for Identification of Human Papillomavirus Types of Low Prevalence
Sabol et al.
J. Clin. Microbiol. 2008;46:1606-1613.
ABSTRACT | FULL TEXT  

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine
Goldie et al.
JNCI J Natl Cancer Inst 2004;96:604-615.
ABSTRACT | FULL TEXT  

Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population
Cuschieri et al.
J. Clin. Pathol. 2004;57:68-72.
ABSTRACT | FULL TEXT  

HLA Class II DR-DQ and Increased Risk of Cervical Cancer among Senegalese Women
Lin et al.
Cancer Epidemiol. Biomarkers Prev. 2001;10:1037-1045.
ABSTRACT | FULL TEXT  

Chlamydia and Cervical Cancer: A Real Association?
Zenilman
JAMA 2001;285:81-83.
FULL TEXT  

Risk Factors for Cervical Intraepithelial Neoplasia in Southwestern American Indian Women
Schiff et al.
Am J Epidemiol 2000;152:716-726.
ABSTRACT | FULL TEXT  

Risk Factors for High-Risk Type Human Papillomavirus Infection among Mexican-American Women
Giuliano et al.
Cancer Epidemiol. Biomarkers Prev. 1999;8:615-620.
ABSTRACT | FULL TEXT  

Hereditary Factors in Gynecologic Cancer
Lynch et al.
The Oncologist 1998;3:319-338.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.